The Future of COVID-19: Vaccines and the Trajectory of Care
March 4, 2021 | 2pm EST
It has now been more than a year since the initial cases of COVID-19 were confirmed in the United States. As the pandemic remains an ongoing health emergency, the approval and rollout of the COVID-19 vaccine and continued development of treatments represent significant milestones in overcoming the disease. However, there are still many questions regarding the long-term trajectory of the virus and its effect on society that our industry is working to understand.
In this webinar, a panel of clinical experts will discuss the current state of COVID-19 and its ever-changing impact both on workers’ compensation and the wider population. We will review emerging FDA treatments, including monoclonal antibodies, and the development of new COVID-19 vaccines. Our clinical experts will also share information to help attendees better understand potential long-term effects of the virus, from the risk of permanent organ impairment to the emergence of COVID long-haulers. Finally, the Paradigm team will present case studies to demonstrate the intersection of COVID and workers’ compensation patients.
Michael Choo, MD, FACEP, FAAEM, Chief Medical Officer, Paradigm
Kathy Galia, RN, BSN, General Manager, Clinical Solutions, Paradigm
Lawrence Lottenberg, MD, FACS, Paradigm Medical Director
Steven M. Gordon, MD, Chairman of the Department of Infectious Diseases, Cleveland Clinic Foundation
CE Credit Information:
One hour of continuing education (CE) credit for the live webinar is approved (or pending where noted) for the following:
- CEU adjuster
- AK, AL, AR, CA (WC & Ind.), DE, FL, GA, ID, IN, KY (pending), LA, MN, MS, MT, NC, NH (WC & Multi), NM, NV, OK, OR, TX, UT, WA (pending), WY
- CE for national nurse
- CCMC national
To see more from Paradigm, please click here.